 CAMBRIDGE, Mass., Oct. 19, 2022 GLOBE NEWSWIRE -- Cerevel Therapeutics Nasdaq: CERE, a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced it will report third quarter 2022 financial results on Tuesday, November 8, 2022, before the U.S. financial markets open. 